SYRS   $2.25  -8.54% Market Open

Syros Pharmaceuticals Inc
Total Cash 78.96M
totalCashPerShare 2.945
EBITDA -116.00M
Total Debt 60.66M
quickRatio 3.22
currentRatio 3.463
Total Revenue 4.15M
debtToEquity
Revenue/Share 0.122
ROA -0.51105
ROE -3.9338598
grossProfits
freeCashflow -67.29M
operatingCashflow -111.19M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -28.34996
profitMargins 0.0
enterpriseValue 34.24M
forwardPE -0.75
floatShares 13.93M
sharesOutstanding 26.81M
sharesShort 999.93K
sharesShortPriorMonth 957.53K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.81%
Short Ratio help_outline 3.01%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue -0.237
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -131.56M
trailingEps -4.35%
forwardEps -2.80%
enterpriseToEbitda -0.29
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.72 3Q 2024
institutionsCount 90
lastUpdated Oct. 21, 2024, 9:29 p.m.